Stock Analysis

When Can We Expect A Profit From Astera Labs, Inc. (NASDAQ:ALAB)?

NasdaqGS:ALAB
Source: Shutterstock

We feel now is a pretty good time to analyse Astera Labs, Inc.'s (NASDAQ:ALAB) business as it appears the company may be on the cusp of a considerable accomplishment. The US$10b market-cap company posted a loss in its most recent financial year of US$26m and a latest trailing-twelve-month loss of US$89m leading to an even wider gap between loss and breakeven. As path to profitability is the topic on Astera Labs' investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts’ expectations for the company.

See our latest analysis for Astera Labs

Astera Labs is bordering on breakeven, according to the 10 American Semiconductor analysts. They expect the company to post a final loss in 2025, before turning a profit of US$37m in 2026. Therefore, the company is expected to breakeven roughly 2 years from now. How fast will the company have to grow each year in order to reach the breakeven point by 2026? Working backwards from analyst estimates, it turns out that they expect the company to grow 71% year-on-year, on average, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

earnings-per-share-growth
NasdaqGS:ALAB Earnings Per Share Growth October 21st 2024

We're not going to go through company-specific developments for Astera Labs given that this is a high-level summary, though, keep in mind that generally a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

Before we wrap up, there’s one aspect worth mentioning. Astera Labs currently has no debt on its balance sheet, which is rare for a loss-making growth company, which usually has a high level of debt relative to its equity. The company currently operates purely off its shareholder funding and has no debt obligation, reducing concerns around repayments and making it a less risky investment.

Next Steps:

There are key fundamentals of Astera Labs which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at Astera Labs, take a look at Astera Labs' company page on Simply Wall St. We've also put together a list of key aspects you should further research:

  1. Valuation: What is Astera Labs worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Astera Labs is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Astera Labs’s board and the CEO’s background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.